P494: A FIRST‐IN‐HUMAN STUDY OF CD123 NK CELL ENGAGER SAR443579 IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR HIGH RISK‐MYELODYSPLASIA
Selwyn Stein, Anthony, Jongen‐Lavrencic, Mojca, Garciaz, Sylvain, A Huls, Gerwin, Maiti, Abhishek, Boissel, Nicolas, De Botton, Stephane, Fleming, Shaun, Michel Zwaan, C., C. de Leeuw, David, Desai, Pinkal, Lucia Arellano, Martha, Avigan, David, Langemeijer, Saskia, Jensen, Kyle, Wagenaar, Timothy, MI, Gu, Abbadessa, Giovanni, Bajel, Ashish
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Safety and efficacy of casein kinase 1α and cyclin dependent kinase 7/9 inhibition in patients with relapsed or refractory AML: A first-in-human study of BTX-A51
Ball, Brian, Borthakur, Gautam, Stein, Anthony Selwyn, Chan, Kyle, Thai, Dung Luong, Stein, Eytan
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Encouraging Efficacy Observed in Bexmab Study: A Phase 1/2 Study to Assess Safety and Efficacy of Bexmarilimab in Combination with Standard of Care in Myeloid Malignancies
Kontro, Mika, Stein, Anthony Selwyn, Pyörälä, Marja, Rimpiläinen, Johanna, Siitonen, Timo, Hollmén, Maija, Fjaellskog, Marie-Louise, Pawlitzky, Inka, Zeidan, Amer M., Daver, Naval
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
First-in-Human Study of the CD123 NK Cell Engager SAR443579 in Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia or High Risk-Myelodysplasia: Updated Safety, Efficacy, Pharmacokinetics and Pharmacodynamics
Bajel, Ashish, Garciaz, Sylvain, Desai, Pinkal, Huls, Gerwin A, Maiti, Abhishek, Jongen-Lavrencic, Mojca, Boissel, Nicolas, De Botton, Stephane, de Leeuw, David C., Fleming, Shaun, Zwaan, C. Michel, Arellano, Martha, Avigan, David, Saultz, Jennifer N., Mantzaris, Ioannis, Jensen, Kyle, Wagenaar, Timothy, Mi, Gu, Ziti-Ljajic, Samira, Draganov, Dobrin, Abbadessa, Giovanni, Stein, Anthony Selwyn
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
What Is the Optimal Treatment Modality in Molecularly Defined Secondary AML? a Multicenter Cohort Study
Shimony, Shai, Bewersdorf, Jan Philipp, Shallis, Rory M., Liu, Yiwen, Schaefer, Eva Johanna, Zeidan, Amer M., Goldberg, Aaron D., Stein, Eytan M., Marcucci, Guido, Chen, Evan C., Ramos, Jorge, Lindsley, R. Coleman, Stein, Anthony Selwyn, DeAngelo, Daniel J., Neuberg, Donna S., Stone, Richard M, Ball, Brian J., Stahl, Maximilian
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Intensive Induction Chemotherapy (IC) Vs Hypomethylating Agents + Venetoclax (HMA/VEN) in IDH1- or IDH2 -Mutant Newly Diagnosed Acute Myeloid Leukemia (AML) - a Multicenter Cohort Study
Bewersdorf, Jan Philipp, Shimony, Shai, Shallis, Rory M., Liu, Yiwen, Schaefer, Eva Johanna, Zeidan, Amer M., Goldberg, Aaron D., Stein, Eytan M., Marcucci, Guido, Lindsley, R. Coleman, Chen, Evan C., Ramos, Jorge, Stein, Anthony Selwyn, DeAngelo, Daniel J., Neuberg, Donna S., Stone, Richard M, Ball, Brian J., Stahl, Maximilian
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Intensive Induction Chemotherapy Vs Hypomethylating Agents + Venetoclax (HMA/VEN) in NPM1 -Mutant Newly Diagnosed Acute Myeloid Leukemia (AML) - a Multicenter Cohort Study
Bewersdorf, Jan Philipp, Shimony, Shai, Shallis, Rory M., Liu, Yiwen, Schaefer, Eva Johanna, Zeidan, Amer M., Goldberg, Aaron D., Stein, Eytan M., Marcucci, Guido, Lindsley, R. Coleman, Chen, Evan C., Ramos, Jorge, Stein, Anthony Selwyn, DeAngelo, Daniel J., Neuberg, Donna S., Stone, Richard M, Ball, Brian J., Stahl, Maximilian
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Safety, Pharmacodynamic, and Anti-Tumor Activity of SL-172154 As Monotherapy and in Combination with Azacitidine (AZA) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) Patients (pts)
Daver, Naval, Stein, Anthony Selwyn, Bixby, Dale, Chai-Ho, Wanxing, Zeidner, Joshua F., Maher, Keri, Stevens, Don A., Stahl, Maximilian, Yee, Karen, Curran, Emily K, Ito, Sawa, Sochacki, Andrew, Sallman, David A, Hernandez, Robert, Metenou, Simon, Ma, Bo, Kato, Kazunobu, Zeidan, Amer M.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A first-in-human study of CD123 NK cell engager SAR443579 in relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high-risk myelodysplasia
Stein, Anthony Selwyn, Jongen-Lavrencic, Mojca, Garciaz, Sylvain, Huls, Gerwin A, Maiti, Abhishek, Boissel, Nicolas, De Botton, Stéphane, Fleming, Shaun, Zwaan, C Michel, C. de Leeuw, David, Desai, Pinkal, Arellano, Martha Lucia, Avigan, David, Langemeijer, Saskia, Jensen, Kyle A., Wagenaar, Timothy, Mi, Gu, Abbadessa, Giovanni, Bajel, Ashish
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A phase 4 study to evaluate outpatient blinatumomab in patients with minimal/measurable residual disease (MRD) positivity (+) of B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
Khan, Sharif S., Mori, Shahram, Jeyakumar, Deepa, Keng, Michael Kenneth, Murthy, Hemant S., Bar-Natan, Michal, Gundabolu, Krishna, O'Dwyer, Kristen M., Rodriguez, Tulio, Stein, Anthony Selwyn, Stock, Wendy, Oliai, Caspian, McCann, Christopher, Zaman, Faraz, Zugmaier, Gerhard, Gordon, Paul, Pardee, Timothy S.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
The impact of infection on health-related quality of life (HRQoL) in patients with Philadelphia negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (Ph- R/R BCP ALL) in a randomized, open-label, phase 3 study (TOWER)
Schuh, Andre C., Li, Yan, Topp, Max S., Zhang, Xinke, Cannell, Paul, Dombret, Herve, Maertens, Johan, Stein, Anthony Selwyn, Franklin, Janet
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Updated results from phase I dose-escalation study of AMG 330, a bispecific T-cell engager molecule, in patients with relapsed/refractory acute myeloid leukemia (R/R AML)
Ravandi, Farhad, Walter, Roland B., Subklewe, Marion, Buecklein, Veit, Jongen-Lavrencic, Mojca, Paschka, Peter, Ossenkoppele, Gert J., Kantarjian, Hagop M., Hindoyan, Antreas, Agarwal, Suresh K, Dai, Tian, Khaldoyanidi, Sophia, Stein, Anthony Selwyn
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Characterization of clinical pharmacokinetics and exposure-response relationships of AMG 330, a bispecific CD33 T-cell engager antibody construct, in patients with relapsed/refractory AML
Agarwal, Suresh K, Bhagwat, Sharvari, Mehta, Khamir, Hindoyan, Antreas, Stein, Anthony Selwyn, Ravandi, Farhad, Subklewe, Marion, Walter, Roland B., Jongen-Lavrencic, Mojca, Ossenkoppele, Gert J., Paschka, Peter, Khaldoyanidi, Sophia, Dutta, Sandeep, Upreti, Vijay V.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Long-term survival of adults with B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) after treatment with blinatumomab and subsequent allogeneic hematopoietic stem cell transplantation (HSCT)
Topp, Max, Stein, Anthony Selwyn, Zugmaier, Gerhard, Dombret, Hervé, Brueggemann, Monika, Bonifacio, Massimiliano, Dong, Xiaoyu, Kantarjian, Hagop M., Bargou, Ralf C., Gökbuget, Nicola
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Superior therapy response predictions for patients with myelodysplastic syndrome (MDS) using Cellworks Singula: MyCare-009-02
Stein, Anthony Selwyn, Watson, Drew, Kapoor, Shweta, Ghosh Roy, Kunal Ghosh, Alam, Aftab, Sahu, Diwyanshu, Basu, Kabya, Prakash, Annapoorna, Ullal, Yashaswini, Raju, Karthik Sundara, Suseela, Rakhi Purushothaman, Joseph, Vishwas, Basu, Sayani, Kumar, Chandan, Mohapatra, Subrat, Kumari, Pallavi, Birajdar, Shivgonda, Gopi, Reshma, Mitra, Upasana, Marcucci, Guido
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Superior therapy response predictions for patients with acute myeloid leukemia (AML) using Cellworks Singula: MyCare-009-01
Marcucci, Guido, Watson, Drew, Kapoor, Shweta, Rajagopalan, Swaminathan, Parashar, Rajan, Alam, Aktar, Sahu, Diwyanshu, Lala, Deepak Anil, Singh, Divya, Basu, Kabya, Grover, Himanshu, G, Poornachandra, Tyagi, Anuj, Macpherson, Michele, Narvekar, Yugandhara, Agrawal, Ashish, Mitra, Upasana, Sauban, Mohammed, Mandal, Rema, Stein, Anthony Selwyn
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Exposure-adjusted adverse events (AEs) comparing blinatumomab to standard of care (SOC) chemotherapy in patients (pts) with relapsed/refractory B-precursor acute lymphoblastic leukemia (r/r ALL) from a randomized phase III study
Stein, Anthony Selwyn, Larson, Richard A., Schuh, Andre C., Stevenson, William, Lech-Maranda, Ewa, Nie, Kun, Zimmerman, Zachary Franklin, Kormany, William, Topp, Max S.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
ALL-071: A Phase 4 Study to Evaluate Outpatient Blinatumomab in Patients with Minimal/Measurable Residual Disease (MRD) Positivity (+) of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)
Khan, Sharif S., Mori, Shahram, Jeyakumar, Deepa, Keng, Michael Kenneth, Murthy, Hemant S., Bar-Natan, Michal, Gundabolu, Krishna, O’Dwyer, Kristen, Rodriguez, Tulio, Stein, Anthony Selwyn, Oliai, Caspian, McCann, Christopher, Zaman, Faraz, Zugmaier, Gerhard, Gordon, Paul, Pardee, Timothy S.
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
Poster: ALL-071: A Phase 4 Study to Evaluate Outpatient Blinatumomab in Patients with Minimal/Measurable Residual Disease (MRD) Positivity (+) of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)
Khan, Sharif S., Mori, Shahram, Jeyakumar, Deepa, Keng, Michael Kenneth, Murthy, Hemant S., Bar-Natan, Michal, Gundabolu, Krishna, O’Dwyer, Kristen, Rodriguez, Tulio, Stein, Anthony Selwyn, Oliai, Caspian, McCann, Christopher, Zaman, Faraz, Zugmaier, Gerhard, Gordon, Paul, Pardee, Timothy S.
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article